To date, the presence of C3 activation fragments and MAC deposition in CE mice, together with the noted amelioration of disease in CE CFB −/− mice supports the hypothesis that AP-mediated activation of the complement system plays a role in CE-induced AMD pathology, through complement-mediated effector mechanisms. The gene discussed is C3; the disease is age-related macular degeneration.